Association of polycythemia vera with positive JAK2V617F mutation and myasthenia gravis: A report of two cases
<p></p><div> <p>Screening for MG in patients with PV positive for JAK2V617F mutation can help in early diagnosis and treatment, resulting in a significant reduction in morbidity and mortality.</p> </div><p></p><h2>Other Information</h2> <...
محفوظ في:
| المؤلف الرئيسي: | Sreethish Sasi (14151873) (author) |
|---|---|
| مؤلفون آخرون: | Mohamed A. Yassin (8361183) (author), Sadat Kamran (14777248) (author), Vazgen Mnatsakanyan (14777251) (author) |
| منشور في: |
2023
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Budd‐Chiari syndrome on background of JAK2V617F mutation with no hematologic abnormalities
حسب: Ammara Bint I Bilal (14777176)
منشور في: (2023) -
International external quality assurance of JAK2 V617F quantification
حسب: Julia Asp (16817103)
منشور في: (2018) -
Ruxolitinib (a JAK2 inhibitor) as an emerging therapy for refractory pruritis in a patient with low-risk polycythemia vera A case report
حسب: Abdulrahman F. Al-Mashdali (16322744)
منشور في: (2021) -
Budd-Chiari syndrome and heparin-induced thrombocytopenia in polycythemia vera
حسب: Mahfoud, Daniel
منشور في: (2009) -
Budd-Chiari syndrome and heparin-induced thrombocytopenia in polycythemia vera: Successful treatment with repeated TIPS and interferon alpha
حسب: Farhat, Hussein
منشور في: (2009)